Patritumab

• Target:

  Akt|||PARP|||ERK|||HER|||EGFR|||Survivin

• Related Pathways:

  Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||PI3K/Akt/mTOR signaling|||DNA Damage/DNA Repair|||Angiogenesis|||MAPK|||Apoptosis|||Cytoskeletal Signaling

• Purity:

  0.982

• Bioactivity:

  Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1262787-83-6